The invention relates to dispersible pharmaceutical compositions comprising deferasirox and one or more pharmaceutically acceptable excipients. More specifically, it relates to dispersible tablet comprising deferasirox, Cremophor® RH 40 and one or more pharmaceutically acceptable excipients, wherein the tablet is prepared by top-spray fluid bed granulation process.